Company / Operating Cash Flow per Share
AXIM BIOTECHNOLOGIES, INC. Operating Cash Flow per Share History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.01
FY2023
5-year range
-$0.09 / -$0.01
FY2019-FY2023
Trend
+63.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 9 years, ranging from $-0.09 in FY2018 to $0.00 in FY2012.
Based on SEC 10-K filings.
-0.01 in FY2023.
Improved from $-0.09 to $-0.01 over the past 5 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating cash flow per share increased 63.8% year-over-year.
- Peak operating cash flow per share was recorded in FY2012.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$0.01 | +63.8% |
| FY2022 | -$0.01 | +83.3% |
| FY2018 | -$0.09 | -51.3% |
| FY2017 | -$0.06 | -79.8% |
| FY2016 | -$0.03 | +30.0% |
| FY2015 | -$0.05 | -4561.6% |
| FY2013 | -$0.00 | -231.3% |
| FY2012 | $0.00 | +277.4% |
| FY2011 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026